MétaCan
Menu
Back to cohort
Record W4200131510 · doi:10.1097/prs.0000000000008658

Medical Directors in Plastic Surgery: How Do We Quantify Their Efforts?

2021· article· en· W4200131510 on OpenAlexaff

Bibliographic record

VenuePlastic & Reconstructive Surgery · 2021
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmaceutical industry and healthcare
Canadian institutionsMcGill University
Fundersnot available
KeywordsAutonomyHealth careAuditQuality (philosophy)Patient safetyClinical PracticeControl (management)Medical careClinical audit

Abstract

fetched live from OpenAlex

The complex nature of the United States’ health care system has largely transformed the manner in which health care providers are evaluated and reimbursed for their efforts. In the operating room, the efforts of plastic surgeons are quantified by either the amount charged or by the relative value units earned from a surgical procedure.1 While such metrics are well established for measuring surgeons’ clinical efforts, there is no consensus regarding the quantification of effort exhibited by plastic surgeons serving as medical directors, despite their importance. Medical directors serve in many sectors of health care. Consequently, methods for quantifying their efforts should be tailored toward their role (Table 1). Directors tasked with overseeing clinical activities are responsible for maintaining and improving the treatment infrastructure in which high-quality health care is provided. Metrics such as patient satisfaction, efficiency of clinical workflow, and results of safety audits may be used to reflect directors’ efforts.2 While each of these variables is easily quantifiable, their use should not be the sole method for measuring a director’s efforts, as heterogeneity in directors’ autonomy across institutions may limit their ability to improve certain aspects of clinical practice.3 Table 1. - Proposed Measures of Medical Directors’ Efforts across Varying Sectors of Health Care Role Proposed Measurement(s) Benefits Limitations Clinical Oversight 1. Patient satisfaction; 2. Clinical efficiency; 3. Safety auditing Metrics correlate with a director’s efforts to ensure quality health care is provided safely and efficiently Significant disparities in decision-making autonomy across institutions Research & Innovation 1. Research output; 2. Funding from grants Accurately quantifies an institution’s contributions to academia Poorly correlated with a director’s efforts Industry 1. Company valuation; 2. Revenue and profit margins Quantifies the financial impact of the director Market dynamics out of directors control can influence these metrics; failure to account for long-term strategies The primary responsibility of medical directors practicing in industry is to ensure the profitability of the company they work for by analyzing the market, identifying opportunities, and advising the procurement and liquidation of valued and paltry assets, respectively.4 One manner of evaluating directors’ efforts in this setting is by observing how strategies developed by directors influence the valuation or growth of the company; however, this form of measurement is not without limitations. Company valuation is not directly representative of a director’s efforts, as it is heavily influenced by fluctuations in the dynamic health care industry. In addition, some strategies developed by the director may be focused on long-term success and may take months or years to influence the valuation of the company. Within academia, many medical directors are responsible for cultivating an environment in which research and innovation are conducted by facilitating the procurement of institutional grants through advocacy and networking.5 In contrast to directors serving in clinical settings and industry, quantifying the efforts of directors’ contributions in academia is more challenging. Metrics such as research output and funding acquired from institutional grants are heavily reliant on the surgeons conducting the research; thus, it can be difficult to delineate the director’s impact in the process. Despite this, sustained levels of high research output and funding from grants deserve recognition when evaluating a director. Plastic surgeons who undertake the role of medical director allot a significant amount of time to fulfill their director-related duties in addition to their extensive clinical responsibilities. Moreover, many directors, with the exception of those working in industry, serve without monetary compensation and are driven to serve secondary to their intrinsic desire to influence the field of medicine. The methods for quantifying the efforts of medical directors that were outlined in this article have utility; however, their limitations warrant further investigation to establish how directors should be rewarded for their contributions. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.103
metaresearch head score (Gemma)0.311
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.103
Threshold uncertainty score0.545

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1030.311
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0130.018
Science and technology studies0.0020.005
Scholarly communication0.0120.016
Open science0.0030.006
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.280
GPT teacher head0.451
Teacher spread0.171 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venuePlastic & Reconstructive SurgerySame topicPharmaceutical industry and healthcareFrench-language works237,207